Dr. Alex Colville joins forces with Laura Deming to lead investments in longevity science moonshots, after deploying $100M fund last year while at Stanford
age1, a venture capital firm catalyzing ...
Chronic diseases like cancer, heart disease and diabetes, first hit the average American in their 60s. Cancer is usually diagnosed at 66, the average age for a first heart attack in ...
Scientists obsessed with aging are sketching a road map of how our bodies change as we grow old in the hopes that it will lead to treatments that could ...
The Atlantic celebrates science, tech, and a culture of curiosity.
Join us to explore how innovation borrows from unexpected corners, featuring Airbnb’s Brian Chesky, Google DeepMind’s Pushmeet Kohli, Anthropic’s Dario ...
The times are changing in biopharma.
With the top drugmakers no longer committing most of their resources to the pandemic, biopharma is returning to its roots. But it’s clear the ...
When a startup called Retro Biosciences eased out of stealth mode in mid-2022, it announced it had secured $180 million to bankroll an audacious mission: to add 10 years to ...
As a postdoctoral researcher at Stanford University, Kristen Fortney used bioinformatics to study the genetics of supercentenarians — people who live to the age of 110 and beyond. Now ...
We sat down with some of the most curious minds in life sciences and healthcare and invited them to share their thoughts on their careers, the future of health ...
“Why is it in popular culture, if you want to live forever, you are evil and you want to kill babies on the side?” says Martin Borch Jensen.
It’s fast ...
Tech billionaires are funding research to help us live longer and healthier lives, but experts warn of an ethical minefield ahead.
When Nir Barzilai specialised in anti-ageing science 30 years ...
Scientists are great at making mice live longer.
Rapamycin, widely prescribed to prevent organ rejection after a transplant, increases the life expectancy of middle-age mice by as much as 60 ...
BioAge Labs, Inc. (“BioAge”), a clinical-stage biotechnology company developing therapeutics that target the molecular causes of aging to extend healthy human lifespan, today announced positive Phase 1b clinical data ...
Research labs are pursuing technology to “reprogram” aging bodies back to youth.
A little over 15 years ago, scientists at Kyoto University in Japan made a remarkable discovery. When they ...
